anti-Lung Carcinoma antibody [CHALU2]

anti-Lung Carcinoma antibody [CHALU2] for Flow cytometry,ICC/IF and Human

Cancer antibody; Gene Regulation antibody


Product Description

Mouse Monoclonal antibody [CHALU2] recognizes Lung Carcinoma

Tested Reactivity Hu
Tested Application FACS, ICC/IF
Specificity No cross reactions to human adult normal tissues and fetal tissues.
Host Mouse
Clonality Monoclonal
Clone CHALU2
Isotype IgG1, kappa
Target Name Lung Carcinoma
Antigen Species Human
Immunogen Human lung carcinoma cells
Conjugation Un-conjugated

Application Instructions

Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.


Form Liquid
Purification Protein G affinity purified
Buffer 0.02M PBS (pH 7.0)
Concentration 1 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.


Background Cancers that derived from epithelium of the lung are called lung carcinoma. Each year, lung carcinoma causes over one million of deaths worldwide. Based on the size of cancer cells, lung carcinoma is grouped into two types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC is strongly associated with smokers. SCLC grows and metastases very fast and responds to surgical resection poorly. NSCLS includes squamous cell carcinoma, adenocarcinoma and large cell carcinoma. Antibodies against lung carcinoma can be used as a guiding tool in bio-missile cancer therapy strategy.
Research Area Cancer antibody; Gene Regulation antibody

Images (1) Click the Picture to Zoom In

  • ARG10082 anti-Lung Carcinoma antibody [CHALU2] Flow Cytometry image

    Flow Cytometry: N9 cells stained with anti-l-Myc antibody [CHALU2] (ARG10082) followed by incubation with fluorescence labelled secondary antibody.